Tissue Additives News
New Tissue Competency Center in Hopewell
A new Tissue Competency Center has been installed at the Evonik branch in Hopewell, Virginia. With this step Evoniks Business Line Interface & Performance underlines its business concept “Face-to-Face Performance”. “Strong application and process expertise in selected markets linked with various test facilities and a global organization are the base for our success” underlines Christian Edlinger, Business Director Americas Interface & Performance.
The Competency Center will provide global support for the Tissue industry with applications development, technical service, training and product development for tissue, pulp and paper applications. Interface & Performance sells softeners and debonders to the tissue and fluff pulp industry under the AROSURF® and VARISOFT® trade names as well as pulp and paper defoamer under the TEGOPREN® trade name. “Defoamers help our customers to reduce the foaming in their mills and thereby increasing the throughput whereas our softeners and debonders provide premium softness for a variety of tissues in the market. The lab can form sheets of paper and test them for various properties such as strength and absorbency,” explains Saji Meledathu, Technology Manager Americas, Interface & Performance.
The Competency Center was built upon the existing regional technical service lab with the addition of new capabilities and equipment. Some of the new equipment includes a spray-on system, a new paper sheet former, and strength analyzers. Newly bought equipment allows also to measure absorbency for fluff pulp which is used in diapers and tissues as well as softness of tissues.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.